The Leadership Team at Infant Bacterial Therapeutics is responsible for setting the strategic vision and direction of the company. Comprised of key executives including the CEO, Chief Medical Officer, and Chief Operating Officer, the team collaborates to oversee clinical development, operational efficiency, and regulatory compliance, all while driving innovations that aim to positively impact the infant microbiome and address rare diseases in infants.
View all